445 related articles for article (PubMed ID: 18987750)
1. Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer.
Yang Y; Pospisil P; Iyer LK; Adelstein SJ; Kassis AI
PLoS One; 2008; 3(11):e3661. PubMed ID: 18987750
[TBL] [Abstract][Full Text] [Related]
2. Serum cancer biomarker discovery through analysis of gene expression data sets across multiple tumor and normal tissues.
Jin H; Lee HC; Park SS; Jeong YS; Kim SY
J Biomed Inform; 2011 Dec; 44(6):1076-85. PubMed ID: 21872680
[TBL] [Abstract][Full Text] [Related]
3. Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum.
Welsh JB; Sapinoso LM; Kern SG; Brown DA; Liu T; Bauskin AR; Ward RL; Hawkins NJ; Quinn DI; Russell PJ; Sutherland RL; Breit SN; Moskaluk CA; Frierson HF; Hampton GM
Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3410-5. PubMed ID: 12624183
[TBL] [Abstract][Full Text] [Related]
4. Biomarker discovery using a comparative omics approach in a mouse model developing heterogeneous mammary cancer subtypes.
Pennings JL; Van Dycke KC; van Oostrom CT; Kuiper RV; Rodenburg W; de Vries A
Proteomics; 2012 Jul; 12(13):2149-57. PubMed ID: 22807454
[TBL] [Abstract][Full Text] [Related]
5. Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy.
Bignotti E; Tassi RA; Calza S; Ravaggi A; Romani C; Rossi E; Falchetti M; Odicino FE; Pecorelli S; Santin AD
Gynecol Oncol; 2006 Nov; 103(2):405-16. PubMed ID: 16725184
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of infiltrating ductal carcinoma tissues by coupled 2-D DIGE/MS/MS analysis.
Davalieva K; Kiprijanovska S; Broussard C; Petrusevska G; Efremov GD
Mol Biol (Mosk); 2012; 46(3):469-80. PubMed ID: 22888636
[TBL] [Abstract][Full Text] [Related]
7. Detection and monitoring of ovarian cancer.
Su Z; Graybill WS; Zhu Y
Clin Chim Acta; 2013 Jan; 415():341-5. PubMed ID: 23165217
[TBL] [Abstract][Full Text] [Related]
8. Methylated genes as new cancer biomarkers.
Duffy MJ; Napieralski R; Martens JW; Span PN; Spyratos F; Sweep FC; Brunner N; Foekens JA; Schmitt M;
Eur J Cancer; 2009 Feb; 45(3):335-46. PubMed ID: 19138839
[TBL] [Abstract][Full Text] [Related]
9. Gene-expression profiling in pancreatic cancer.
López-Casas PP; López-Fernández LA
Expert Rev Mol Diagn; 2010 Jul; 10(5):591-601. PubMed ID: 20629509
[TBL] [Abstract][Full Text] [Related]
10. Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data.
Kim B; Lee HJ; Choi HY; Shin Y; Nam S; Seo G; Son DS; Jo J; Kim J; Lee J; Kim J; Kim K; Lee S
Cancer Res; 2007 Aug; 67(15):7431-8. PubMed ID: 17671213
[TBL] [Abstract][Full Text] [Related]
11. Proteomic profiling of mammary carcinomas identifies C7orf24, a gamma-glutamyl cyclotransferase, as a potential cancer biomarker.
Gromov P; Gromova I; Friis E; Timmermans-Wielenga V; Rank F; Simon R; Sauter G; Moreira JM
J Proteome Res; 2010 Aug; 9(8):3941-53. PubMed ID: 20527979
[TBL] [Abstract][Full Text] [Related]
12. Global gene expression profiling of circulating tumor cells.
Smirnov DA; Zweitzig DR; Foulk BW; Miller MC; Doyle GV; Pienta KJ; Meropol NJ; Weiner LM; Cohen SJ; Moreno JG; Connelly MC; Terstappen LW; O'Hara SM
Cancer Res; 2005 Jun; 65(12):4993-7. PubMed ID: 15958538
[TBL] [Abstract][Full Text] [Related]
13. Relevant genomics of neurotensin receptor in cancer.
Elek J; Pinzon W; Park KH; Narayanan R
Anticancer Res; 2000; 20(1A):53-8. PubMed ID: 10769634
[TBL] [Abstract][Full Text] [Related]
14. General approach to identifying potential targets for cancer imaging by integrated bioinformatics analysis of publicly available genomic profiles.
Yang Y; Adelstein SJ; Kassis AI
Mol Imaging; 2011 Apr; 10(2):123-34. PubMed ID: 21439257
[TBL] [Abstract][Full Text] [Related]
15. An integrated clinical-genomics approach identifies a candidate multi-analyte blood test for serous ovarian carcinoma.
Meinhold-Heerlein I; Bauerschlag D; Zhou Y; Sapinoso LM; Ching K; Frierson H; Bräutigam K; Sehouli J; Stickeler E; Könsgen D; Hilpert F; von Kaisenberg CS; Pfisterer J; Bauknecht T; Jonat W; Arnold N; Hampton GM
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):458-66. PubMed ID: 17255266
[TBL] [Abstract][Full Text] [Related]
16. Digital transcript profile analysis with aRNA-LongSAGE validates FERMT1 as a potential novel prognostic marker for colon cancer.
Fan J; Yan D; Teng M; Tang H; Zhou C; Wang X; Li D; Qiu G; Peng Z
Clin Cancer Res; 2011 May; 17(9):2908-18. PubMed ID: 21220475
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of carcinoembryonic antigen (CEA) splice variants in whole blood of colon cancer patients and healthy volunteers: implication for the detection of circulating colon cancer cells.
Hampton R; Walker M; Marshall J; Juhl H
Oncogene; 2002 Nov; 21(51):7817-23. PubMed ID: 12420218
[TBL] [Abstract][Full Text] [Related]
18. Novel blood biomarkers of pancreatic cancer-associated diabetes mellitus identified by peripheral blood-based gene expression profiles.
Huang H; Dong X; Kang MX; Xu B; Chen Y; Zhang B; Chen J; Xie QP; Wu YL
Am J Gastroenterol; 2010 Jul; 105(7):1661-9. PubMed ID: 20571492
[TBL] [Abstract][Full Text] [Related]
19. A data-mining approach to biomarker identification from protein profiles using discrete stationary wavelet transform.
Montazery-Kordy H; Miran-Baygi MH; Moradi MH
J Zhejiang Univ Sci B; 2008 Nov; 9(11):863-70. PubMed ID: 18988305
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel candidate oncogenes in pancreatic carcinoma using high-throughput microarrays.
Jiang Y; Liu M; Li Z; Jiang Y
Hepatogastroenterology; 2013; 60(128):1825-32. PubMed ID: 24719914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
